Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Double-simulation, Active Comparator-controlled, Parallel-group Phase II Clinical Study to Evaluate the Efficacy and Safety of X842 Capsules at Different Dosages in Patients With Reflux Esophagitis

NCT04531475 is registered in ClinicalTrials.gov with Jiangsu Sinorda Biomedicine Co., Ltd as lead sponsor.

NCT NCT04531475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04531475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Double-simulation, Active Comparator-controlled, Parallel-group Phase II Clinical Study to Evaluate the Efficacy and Safety of X842 Capsules at Different Dosages in Patients With Reflux Esophagitis
Lead sponsor
Jiangsu Sinorda Biomedicine Co., Ltd
Phase
Phase 2
Overall status
Completed
Start date
January 21, 2020
Completion date
January 12, 2021
Enrollment
90 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

reflux esophagitis